An overview of the Randox KRAS BRAF PIK3CA* Array, a molecular assay utilising innovative biochip array technology (BAT) to simultaneously detect 20 point mutations within the KRAS, BRAF and PIK3CA genes, in cases of colorectal cancer, to determine mutational status and/or predict therapy response, from fresh/frozen and formalin fixed paraffin embedded (FFPE) tissue DNA within 3 hours. *PIK3CA for research use only.
DiagnosticsGenomicsMicrofluidicsProteomics and Metabolomics